look news india
Serum Institute's clarification on Covishield vaccine: British pharmaceutical company AstraZeneca has decided to withdraw the corona vaccine Covishield in view of its side effects. Apart from this, the production of this vaccine has also been stopped. Meanwhile, a big statement from Serum Institute of India (SII) has also come out. Serum Institute produced and marketed the Covishield vaccine in India.
Serum Institute empty handed?
The Serum Institute said it had disclosed all vaccine side effects, including thrombosis with thrombocytopenia syndrome (TTS), in a packaging insert at the start of vaccine supply in 2021, but AstraZeneca acknowledged that blood clots could form after receiving the Covishield vaccine. Can. There was an uproar around the world
Covishield is based on Vaxjaveria's formula
Serum Institute said the company stopped production and supply of the vaccine in December 2021 due to low demand. British company AstraZeneca has recalled stocks of its corona vaccine Vaxjavria from countries around the world.
A serum manufactured in India called Covishield
This vaccine was being made by Serum Institute in India, but the name of the vaccine being made in India was Covishield and this medicine was made according to the same formula from which Vaxjavriya is made. AstraZeneca has withdrawn the vaccine, but the Serum Institute has not yet decided to withdraw the vaccine. AstraZeneca has launched an updated version of the vaccine in the market and has withdrawn the stock of the older version. The company had earlier decided to withdraw Vaxjavria from the market on March 5, but the order was implemented on May 7.
